ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $773,000 | +14.9% | 188,475 | -0.1% | 0.00% | 0.0% |
| Q4 2021 | $673,000 | -28.9% | 188,613 | -27.4% | 0.00% | 0.0% |
| Q3 2021 | $946,000 | -23.8% | 259,935 | -8.7% | 0.00% | -50.0% |
| Q2 2021 | $1,241,000 | +13.0% | 284,654 | +6.6% | 0.00% | +100.0% |
| Q1 2021 | $1,098,000 | -2.0% | 267,136 | -4.9% | 0.00% | -50.0% |
| Q4 2020 | $1,120,000 | +58.9% | 280,816 | +7.6% | 0.00% | +100.0% |
| Q3 2020 | $705,000 | -8.1% | 260,961 | -6.4% | 0.00% | 0.0% |
| Q2 2020 | $767,000 | +46.7% | 278,741 | +25.8% | 0.00% | 0.0% |
| Q1 2020 | $523,000 | -50.0% | 221,650 | -0.5% | 0.00% | -50.0% |
| Q4 2019 | $1,047,000 | +46.6% | 222,750 | +4.4% | 0.00% | +100.0% |
| Q3 2019 | $714,000 | +1.0% | 213,446 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $707,000 | +26.9% | 215,021 | +17.0% | 0.00% | 0.0% |
| Q1 2019 | $557,000 | +9.6% | 183,705 | -1.7% | 0.00% | 0.0% |
| Q4 2018 | $508,000 | +21.8% | 186,863 | +50.7% | 0.00% | 0.0% |
| Q3 2018 | $417,000 | +21.2% | 124,006 | -6.9% | 0.00% | 0.0% |
| Q2 2018 | $344,000 | +27.4% | 133,241 | +8.5% | 0.00% | 0.0% |
| Q1 2018 | $270,000 | +8.9% | 122,816 | -1.4% | 0.00% | 0.0% |
| Q4 2017 | $248,000 | -49.1% | 124,616 | -17.1% | 0.00% | 0.0% |
| Q3 2017 | $487,000 | +3.0% | 150,288 | +2.3% | 0.00% | 0.0% |
| Q2 2017 | $473,000 | +261.1% | 146,925 | -2.3% | 0.00% | – |
| Q1 2016 | $131,000 | -28.0% | 150,355 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $182,000 | -21.6% | 150,355 | +10.3% | 0.00% | 0.0% |
| Q3 2015 | $232,000 | -15.6% | 136,350 | +3.3% | 0.00% | 0.0% |
| Q2 2015 | $275,000 | -14.3% | 132,048 | +11.3% | 0.00% | 0.0% |
| Q1 2015 | $321,000 | +30.0% | 118,608 | +23.6% | 0.00% | 0.0% |
| Q4 2014 | $247,000 | +45.3% | 95,958 | +3.0% | 0.00% | 0.0% |
| Q3 2014 | $170,000 | -31.7% | 93,133 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $249,000 | -25.0% | 93,133 | -1.9% | 0.00% | 0.0% |
| Q1 2014 | $332,000 | -26.2% | 94,965 | -5.5% | 0.00% | 0.0% |
| Q4 2013 | $450,000 | +2.7% | 100,465 | -6.8% | 0.00% | 0.0% |
| Q3 2013 | $438,000 | +3.3% | 107,765 | +5.8% | 0.00% | 0.0% |
| Q2 2013 | $424,000 | – | 101,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |